For example, in human 1321N1 astrocytoma cells, the activation of P2Y2R enhanced the release of sAPP alpha, the non-amyloidogenic product of APP with neuroprotective properties, deriving from the alpha-secretase activity. Here, P2RY2 is linked to astrocytoma (excluding glioblastoma).